3-[4-[BIS-(DIETHOXY-PHOSPHORYL)-METHYL]-PHENYL]-(S)-2-TERT.-BUTOXYCARBONYLAMINO-PROPIONIC-ACID-METHYLESTER
Compound with spectra: 1 NMR
![3-[4-[BIS-(DIETHOXY-PHOSPHORYL)-METHYL]-PHENYL]-(S)-2-TERT.-BUTOXYCARBONYLAMINO-PROPIONIC-ACID-METHYLESTER](/api/compound/B4LTfxPXWHk.png?ph=true&h=300&w=458 "3-[4-[BIS-(DIETHOXY-PHOSPHORYL)-METHYL]-PHENYL]-(S)-2-TERT.-BUTOXYCARBONYLAMINO-PROPIONIC-ACID-METHYLESTER")
| SpectraBase Compound ID | B4LTfxPXWHk |
|---|---|
| InChI | InChI=1S/C24H41NO10P2/c1-9-31-36(28,32-10-2)22(37(29,33-11-3)34-12-4)19-15-13-18(14-16-19)17-20(21(26)30-8)25-23(27)35-24(5,6)7/h13-16,20,22H,9-12,17H2,1-8H3,(H,25,27)/t20-/m0/s1 |
| InChIKey | OKRZBVXWTXTLBF-FQEVSTJZSA-N |
| Mol Weight | 565.5 g/mol |
| Molecular Formula | C24H41NO10P2 |
| Exact Mass | 565.220571 g/mol |
| Enantiomer InChIKey | OKRZBVXWTXTLBF-HXUWFJFHSA-N |
| Racemate InChIKey | OKRZBVXWTXTLBF-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
t-Butyl 3-(1',3'-benzodioxol-5'-yl)-2-[(t-butoxycarbonyl)amino]-propanoate
N-carboxy-L-3-phenylalanine, N-benzyl o-nitrophenyl ester
tert-Butyl-oxy-carbonyl-L-valyl-L-valyl-(methyl-L-phenylalanin
DIETHYL-3-(N-(BENZYLOXY)-ACETAMIDO)-1-(4-METHOXYPHENYL)-PROPYLPHOSPHONATE
BOC-PHE-CYS(ME)-ALA-OALL
1-Hexanol, (4S)-[(tert.butyloxycarbonyl)-(S)-phenylalanylamino]-2,3-epoxy-5-methyl-
(S)-3-BENZYLOXYCARBONYL-4-(4-ACETOXYBENZYL)-OXAZOLIDIN-5-ONE
(+,-)-N-[(3-hydroxy-4-methoxyphenyl)acetyl]-3-methoxytyrosine methyl ester
pentanoic acid, 5-amino-4-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-3-[4-(phenylmethoxy)phenyl]propyl]amino]-5-oxo-, phenylmethyl ester
METHYL-(4S,1'S)-2-[1-(TERT.-BUTOXYCARBONYLAMINO)-2-PHENYLETHYL]-4,5-DIHYDROOXAZOLE-4-CARBOXYLATE
| Title | Journal or Book | Year |
|---|---|---|
| X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor | Journal of Medicinal Chemistry | 2001 |